This document discusses aminoglycoside antibiotics. It describes their mechanism of action as inhibiting protein synthesis by binding to bacterial ribosomes. It outlines their pharmacokinetics, including that they are not absorbed orally and are administered via injection. It also covers their uses for treating various bacterial infections like tuberculosis, UTIs, and pneumonia.